Clinical Trial Update: Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Alfimeprase to dissolve leg blood clots and possibly avoid surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Arterial Occlusive Diseases | Phase 3 | Status: TERMINATED